Health Care

XLV dominates the US health care segment on practically every measure. Not only is XLV the oldest and largest fund in the segment, its trading volume dwarfs its closest competitors making XLV's liquidity unparalleled in the segment. It is also relatively cheap amongst peers. The fund tracks its index well, so real-world costs are roughly in line with the headline fee. Since XLV is both cap weighted and fishes only from the S&P 500, it tilts heavily toward mega-caps. The holdings are also more concentrated than most peer funds. For extremely liquid exposure with extra emphasis on leading health care names, XLV is tough to beat.